The Influence of Pharmacological Preconditioning with Sevoflurane on Incidence of Early Allograft Dysfunction in Liver Transplant Recipients

Table 6

The influence of degree of macrovesicular steatosis on protective effects of sevoflurane preconditioning.

Macrovesicular steatosis	Incidence of EAD, %		Fisher’s exact test, two-tailed 𝑃 value
	Sevoflurane group	Control group
None (0%)	11,1 (1 of 9)	11,1 (1 of 9)	1,000
Mild (1–30%)	18,8 (3 of 16)	60,0 (9 of 15)	0,029
Moderate (31–60%)	20,0 (1 of 5)	83,3 (5 of 6)	0,080

EAD: early allograft dysfunction.